E.S. Pronker

501 total citations
15 papers, 342 citations indexed

About

E.S. Pronker is a scholar working on Management of Technology and Innovation, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, E.S. Pronker has authored 15 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Management of Technology and Innovation, 5 papers in Economics and Econometrics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in E.S. Pronker's work include Pharmaceutical Economics and Policy (5 papers), Intellectual Property and Patents (3 papers) and Influenza Virus Research Studies (2 papers). E.S. Pronker is often cited by papers focused on Pharmaceutical Economics and Policy (5 papers), Intellectual Property and Patents (3 papers) and Influenza Virus Research Studies (2 papers). E.S. Pronker collaborates with scholars based in Netherlands, Germany and Israel. E.S. Pronker's co-authors include Eric Claassen, Harry Commandeur, T.C. Weenen, Albert D. M. E. Osterhaus, Adam F. Cohen, Bart F. Geerts, Joost H. C. M. Kreijtz, Sorana C. Iancu, Linda van de Burgwal and Yves Boirie‌ and has published in prestigious journals such as PLoS ONE, Technological Forecasting and Social Change and Vaccine.

In The Last Decade

E.S. Pronker

15 papers receiving 310 citations

Peers

E.S. Pronker

HEALT

PHEOH

T.C. Weenen Netherlands

Brigid E. Cakouros United States

Souleymane Kone United States

Amie Batson United States

Shannon Larsen United States

Sheng-I Chen United States

Enrico Palermo Italy

Paul Adepoju Nigeria

Philippe Jaillard France

Dimitrios Gouglas United States

T.C. Weenen Netherlands

E.S. Pronker

136 ×0.9

70 ×1.0

HEALT

55 ×0.8

79 ×1.4

32 ×0.6

PHEOH

Citations per year, relative to E.S. Pronker E.S. Pronker (= 1×) peers T.C. Weenen

Countries citing papers authored by E.S. Pronker

Since Specialization

Citations

This map shows the geographic impact of E.S. Pronker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.S. Pronker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.S. Pronker more than expected).

Fields of papers citing papers by E.S. Pronker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.S. Pronker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.S. Pronker. The network helps show where E.S. Pronker may publish in the future.

Co-authorship network of co-authors of E.S. Pronker

This figure shows the co-authorship network connecting the top 25 collaborators of E.S. Pronker. A scholar is included among the top collaborators of E.S. Pronker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.S. Pronker. E.S. Pronker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Burgwal, Linda van de, Leslie A. Reperant, Albert D. M. E. Osterhaus, et al.. (2016). Self-Centric and Altruistic Unmet Needs for Ebola: Barriers to International Preparedness. Disaster Medicine and Public Health Preparedness. 10(4). 644–648. 9 indexed citations

Pronker, E.S., et al.. (2015). Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis. Vaccine. 33(35). 4349–4358. 10 indexed citations

Weenen, T.C., E.S. Pronker, Harry Commandeur, & Eric Claassen. (2014). Knowledge diffusion in the European medical nutrition industry. PharmaNutrition. 2(3). 93–93. 1 indexed citations

Pronker, E.S., T.C. Weenen, Harry Commandeur, Eric Claassen, & A.D.M.E. Osterhaus. (2014). Scratching the surface: Exploratory analysis of key opinion leaders on rate limiting factors in novel adjuvanted-vaccine development. Technological Forecasting and Social Change. 90. 420–432. 6 indexed citations

Pronker, E.S., et al.. (2013). Risk in Vaccine Research and Development Quantified. PLoS ONE. 8(3). e57755–e57755. 169 indexed citations

Weenen, T.C., et al.. (2013). Food-Pharma Convergence in Medical Nutrition– Best of Both Worlds?. PLoS ONE. 8(12). e82609–e82609. 20 indexed citations

Pronker, E.S., et al.. (2013). Patenting in the European medical nutrition industry: Trends, opportunities and strategies. PharmaNutrition. 1(1). 13–21. 17 indexed citations

Pronker, E.S., et al.. (2013). Patient needs and research priorities in the enteral nutrition market – A quantitative prioritization analysis. Clinical Nutrition. 33(5). 793–801. 11 indexed citations

Pronker, E.S.. (2013). Innovation Paradox in Vaccine Target Selection. RePub (Erasmus University, Rotterdam). 15 indexed citations

10.

Weenen, T.C., et al.. (2013). A decision framework to evaluate intellectual property strategies in the medical nutrition market. PharmaNutrition. 1(2). 65–72. 8 indexed citations

11.

Pronker, E.S., et al.. (2013). Barriers to innovation in the medical nutrition industry: A quantitative key opinion leader analysis. PharmaNutrition. 1(3). 79–85. 17 indexed citations

12.

Pronker, E.S., et al.. (2012). Development of new generation influenza vaccines. Vaccine. 30(51). 7344–7347. 9 indexed citations

13.

Pronker, E.S., et al.. (2012). Entrepreneurship and science-based venturing The case of vaccine development. Data Archiving and Networked Services (DANS). 1 indexed citations

14.

Pronker, E.S., et al.. (2011). The gold industry standard for risk and cost of drug and vaccine development revisited. Vaccine. 29(35). 5846–5849. 35 indexed citations

15.

Pronker, E.S., et al.. (2010). Improving the quality of drug research or simply increasing its cost? An evidence‐based study of the cost for data monitoring in clinical trials. British Journal of Clinical Pharmacology. 71(3). 467–470. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact